Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-22-308750
Filing Date
2022-12-20
Accepted
2022-12-20 07:21:15
Documents
6

Document Format Files

Seq Description Document Type Size
1 424B5 d432084d424b5.htm 424B5 438960
2 GRAPHIC g432084g04a37.jpg GRAPHIC 32281
3 GRAPHIC g432084g33a01.jpg GRAPHIC 34739
4 GRAPHIC g432084g39a01.jpg GRAPHIC 114970
5 GRAPHIC g432084g41a01.jpg GRAPHIC 100227
6 GRAPHIC g432084g69a01.jpg GRAPHIC 45111
  Complete submission text file 0001193125-22-308750.txt   872025
Mailing Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404
Business Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 650-525-5535 EXT.101
Terns Pharmaceuticals, Inc. (Filer) CIK: 0001831363 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-263370 | Film No.: 221472834
SIC: 2834 Pharmaceutical Preparations